Capital Markets & Financing
American Business Confidence in China Slumps to Lowest in Decades
U.S. companies are painting the bleakest picture in decades over doing business in China as tensions between Beijing and the West are compounded by a deteriorating environment for their operations.
科律助力宜明昂科成功香港上市
宜明昂科生物医药技术（上海）股份有限公司（以下简称“宜明昂科”，股票代码：1541.HK）于今日在香港联合交易所主板正式挂牌上市。科律律师事务所（Cooley LLP）作为宜明昂科的国际律师，为公司的成功上市全程提供法律服务。
China to Set Up New Agency to Promote Private Sector Growth
China’s top economic planner is creating a new department to help private businesses, the latest step by the government to revive confidence in the sector and bolster growth.
China: The latest medtech access policies and implications
In May 2023, NHSA indicated a change of direction from top-down management to a bottom-up approach, issuing policies requesting NRMDL to be established in all provinces by 2025.
Grit Biotechnology Announces Closing of $60 Million Series B Financing
On September 8, 2023, Grit Biotechnology announced the completion of a Series B financing round, raising over 60 million USD.
General Administration of Customs: The total value of imports and exports in the first eight months of this year was 8.27 trillion yuan, a slight decrease of 08.0%
According to the website of the General Administration of Customs on September 9, according to customs statistics, in the first eight months of this year, the total value of China's imports and exports was 7.8 trillion yuan, a slight decrease of 27.08% year-on-year.
BlackRock Pulls Back From China Under Intense Pressure
BlackRock is closing its China Flexible Equity fund as of November 7, 2023, the firm announced in an August 31 shareholder letter.
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
Board of Directors Unanimously Recommends Sinovac Shareholders NOT Tender Shares for purchase pursuant to the Offer to Purchase
树兰医疗递表港交所：华东最大的社会办医疗机构，另已合作14家医疗机构
“据IPO早知道消息，树兰医疗管理股份有限公司（以下简称“树兰医疗”）于2023年8月28日正式向港交所递交招股说明书，中金公司和中信证券担任联席保荐人。成立于2013年的树兰医疗作为一家集健康医疗服务、医学科研、医学教育为一体的中国科技型社会办医疗集团，截至2023年3月31日拥有并运营三家社会办综合医疗机构，并已向中国14家合作医院提供医院管理服务。同时，树兰医疗还提供数字医疗平台服务、医疗检验服务、临床试验服务、供应链服务等多项平台服务。具体来看树兰医疗的三大业务板块：其一、健康医疗服务。截至目前，树兰医疗拥有树兰(杭州)医院、树兰(安吉)医院以及树兰(衢州)医院三家社会办医综合医疗机构——其中，树兰(杭州)医院是树兰医疗于2015年12月开始运营的首家医院，其是少数获评三級甲等医院的社会办医疗机构，并于2017年成为通过JCI认证的国际医院。截至2023年3月31日，树兰(杭州)医院已开设1,000张床位，并设有46个临床专科和13个医技科室。” Continue reading at the original source, linked here.
Innovac Therapeutics Completes $18 million Series Pre-A Financing To Fund the Development of Its lead Programs and Manufacturing Capabilities
Innovac Therapeutics, an mRNA therapeutics company, today announced the completion of an $18 million Series Pre-A financing
